Brian has served as a financial executive in high growth companies for over twenty years, within and outside of the life sciences industry. From 2011 to 2016, Mr. Conn served as Chief Financial Officer for Verdezyne Inc., raising $170 million in equity, debt, project finance and government incentives. Prior to Verdezyne, Mr. Conn held executive positions, including Chief Financial Officer with Chemicon International, Serologicals Corporation, Millipore Corporation and MicroIslet Inc. He has extensive experience with capital transactions, mergers and acquisitions, commercial operations and startups. Mr. Conn holds a Bachelor of Science degree in Finance from Arizona State University.